Guest guest Posted August 1, 2010 Report Posted August 1, 2010 Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C -- PSI-938 single ascending dose study in healthy volunteers supports progression to 7 day monotherapy study in HCV infected patients -- PSI-938 was generally safe and well tolerated with no dose-limiting toxicity -- Further results from single ascending and multiple ascending dose trials are expected in the third quarter 2010 I found this on the business page. Below is the link to the page on the article. I was just wondering if this a drug that we would be able to take without peg/rib combo. I am going to ask my doctor about it. here is link http://finance./news/Pharmasset-Initiates-Phase-1b-prnews-539778225.htm\ l?x=0 & .v=1 Thanks Lois Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.